Publicaciones en colaboración con investigadores/as de Hospital Universitario de Salamanca (43)

2021

  1. Albuminuria pre-emptively identifies cardiac patients at risk of contrast-induced nephropathy

    Journal of Clinical Medicine, Vol. 10, Núm. 21

2020

  1. Urinary transferrin pre-emptively identifies the risk of renal damage posed by subclinical tubular alterations

    Biomedicine and Pharmacotherapy, Vol. 121

2018

  1. Influence of angiogenic mediators and bone remodelling in paget´s disease of bone

    International Journal of Medical Sciences, Vol. 15, Núm. 11, pp. 1210-1216

  2. Risk of hospitalization associated with body mass index and weight changes among prevalent haemodialysis patients

    Nefrologia, Vol. 38, Núm. 5, pp. 520-527

2017

  1. Association of VAV2 and VAV3 polymorphisms with cardiovascular risk factors

    Scientific Reports, Vol. 7

2016

  1. Absence of K-Ras Reduces Proliferation and Migration But Increases Extracellular Matrix Synthesis in Fibroblasts

    Journal of Cellular Physiology, Vol. 231, Núm. 10, pp. 2224-2235

  2. Association between different risk factors and vascular accelerated ageing (EVA study): Study protocol for a cross-sectional, descriptive observational study

    BMJ Open, Vol. 6, Núm. 6

  3. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease

    Kidney International, Vol. 90, Núm. 1, pp. 77-89

  4. Identification of bone morphogenetic protein 9 (BMP9) as a novel profibrotic factor in vitro

    Cellular Signalling, Vol. 28, Núm. 9, pp. 1252-1261

  5. Mechanisms of triple whammy acute kidney injury

    Pharmacology and Therapeutics, Vol. 167, pp. 132-145

  6. Serum Superoxide Dismutase Is Associated with Vascular Structure and Function in Hypertensive and Diabetic Patients

    Oxidative Medicine and Cellular Longevity, Vol. 2016

2015

  1. Increased Klk9 urinary excretion is associated to hypertension-induced cardiovascular damage and renal alterations

    Medicine (United States), Vol. 94, Núm. 41

  2. Plasma cardiotrophin-1 as a marker of hypertension and diabetes-induced target organ damage and cardiovascular risk

    Medicine (United States), Vol. 94, Núm. 30

  3. TGF-β/BMP proteins as therapeutic targets in renal fibrosis. Where have we arrived after 25 years of trials and tribulations?

    Pharmacology and Therapeutics, Vol. 156, pp. 44-58

2014

  1. ALK1 heterozygosity increases extracellular matrix protein expression, proliferation and migration in fibroblasts

    Biochimica et Biophysica Acta - Molecular Cell Research, Vol. 1843, Núm. 6, pp. 1111-1122

  2. Heterozygous disruption of activin receptor-like kinase 1 is associated with increased renal fibrosis in a mouse model of obstructive nephropathy

    Kidney International, Vol. 85, Núm. 2, pp. 319-332

  3. Hypertension and hyperglycemia synergize to cause incipient renal tubular alterations resulting in increased NGAL urinary excretion in rats

    PLoS ONE, Vol. 9, Núm. 8

2013

  1. Concerted action of ANP and dopamine D1-receptor to regulate sodium homeostasis in nephrotic syndrome

    BioMed Research International, Vol. 2013

  2. Influence of body mass index on the association of weight changes with mortality in hemodialysis patients

    Clinical Journal of the American Society of Nephrology, Vol. 8, Núm. 10, pp. 1725-1733

  3. TNF-related weak inducer of apoptosis (TWEAK) promotes kidney fibrosis and Ras-dependent proliferation of cultured renal fibroblast

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1832, Núm. 10, pp. 1744-1755